BioDiem Ltd - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions. - Corporate strategy – Analyst’s summarization of the company’s business strategy. - SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats. - Company history – Progression of key events associated with the company. - Major products and services – A list of major products, services and brands of the company. - Key competitors – A list of key competitors to the company. - Key employees – A list of the key executives of the company. - Executive biographies – A brief summary of the executives’ employment history. - Key operational heads – A list of personnel heading key departments/functions. - Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company. - Key manufacturing facilities – A list of key manufacturing facilities of the company. - Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history. - Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
BioDiem Ltd. (BioDiem) is an Australian biotechnology company based in Melbourne, with a focus on developing and commercializing vaccines and infectious disease therapies. The company develops vaccines and novel therapeutic candidates for the treatment of seasonal and pandemic influenza, antimicrobial and antifungal, and retinal disease. It receives revenues from vaccine licenses in India and China.
BioDiem Ltd Key Recent Developments
Dec 05, 2013: BioDiem Announces Publication of Research in Journal of Virology Oct 28, 2013: BioDiem Announces Confirmation of Delisting from ASX Oct 25, 2013: BioDiem Announces Change of Principal Place of Business and Registered Office Oct 24, 2013: China presentation of BioDiem’s liver treatment technology Aug 30, 2013: BioDiem Reports Proposed Delisting from ASX
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table Of Contents
BioDiem Ltd - Financial and Strategic SWOT Analysis Review Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Section 1 - About the Company 5 BioDiem Ltd - Key Facts 5 BioDiem Ltd - Key Employees 6 BioDiem Ltd - Key Employee Biographies 7 BioDiem Ltd - Key Operational Employees 8 BioDiem Ltd - Major Products and Services 9 BioDiem Ltd - Pharmaceutical Pipeline Products Data 10 BioDiem Ltd, Pipeline Products by Therapy Area 10 BioDiem Ltd, Pipeline Products by Development Phase 11 BioDiem Ltd - History 13 BioDiem Ltd - Locations And Subsidiaries 15 Head Office 15 Other Locations and Subsidiaries 15 Section 2 - Company Analysis 16 BioDiem Ltd - Business Description 16 BioDiem Ltd - SWOT Analysis 17 SWOT Analysis - Overview 17 BioDiem Ltd - Strengths 17 Strength - LAIV Technology 17 Strength - Strong Research and Development Capabilities 17 Strength - Global Partnering/Commercialization Network 17 BioDiem Ltd - Weaknesses 17 Weakness - Negative Operating Margin 17 Weakness - Limited Liquidity Position 17 BioDiem Ltd - Opportunities 18 Opportunity - Product Pipeline 18 Opportunity - Potential Market 18 Opportunity - Changing Demographics 18 BioDiem Ltd - Threats 18 Threat - Competition 18 Threat - Uncertain RandD Outcomes 18 BioDiem Ltd - Key Competitors 19 Section 3 - Company Financial Ratios 20 Financial Ratios - Capital Market Ratios 20 Financial Ratios - Annual Ratios 20 Performance Chart 22 Financial Performance 22 Financial Ratios - Interim Ratios 23 Financial Ratios - Ratio Charts 24 Section 4 - Company's Lifesciences Financial Deals and Alliances 25 BioDiem Ltd, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25 BioDiem Ltd, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 26 BioDiem Ltd, Recent Deals Summary 27 Section 5 - Company's Recent Developments 28 BioDiem Ltd, Recent Developments 28 Dec 05, 2013: BioDiem Announces Publication of Research in Journal of Virology 28 Oct 28, 2013: BioDiem Announces Confirmation of Delisting from ASX 28 Oct 25, 2013: BioDiem Announces Change of Principal Place of Business and Registered Office 28 Oct 24, 2013: China presentation of BioDiem's liver treatment technology 29 Aug 30, 2013: BioDiem Reports Proposed Delisting from ASX 29 Jul 22, 2013: Proof of Principle shown in liver disease vaccine program 30 Section 6 - Appendix 31 Methodology 31 Ratio Definitions 31 About GlobalData 35 Contact Us 35 Disclaimer 35
List of Tables
BioDiem Ltd, Key Facts 5 BioDiem Ltd, Key Employees 6 BioDiem Ltd, Key Employee Biographies 7 BioDiem Ltd, Key Operational Employees 8 BioDiem Ltd, Major Products and Services 9 BioDiem Ltd, Number of Pipeline Products by Therapy Area 10 BioDiem Ltd, Number of Pipeline Products by Development Stage 11 BioDiem Ltd, Pipeline Products By Therapy Area and Development Phase 12 BioDiem Ltd, History 13 BioDiem Ltd, Subsidiaries 15 BioDiem Ltd, Key Competitors 19 BioDiem Ltd, Ratios based on current share price 20 BioDiem Ltd, Annual Ratios 20 BioDiem Ltd, Interim Ratios 23 BioDiem Ltd, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25 BioDiem Ltd, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 26 BioDiem Ltd, Recent Deals Summary 27 Currency Codes 31 Capital Market Ratios 31 Equity Ratios 32 Profitability Ratios 32 Cost Ratios 33 Liquidity Ratios 33 Leverage Ratios 34 Efficiency Ratios 34
List of Figures
BioDiem Ltd, Pipeline Products by Therapy Area 10 BioDiem Ltd, Pipeline Products by Development Phase 11 BioDiem Ltd, Performance Chart (2009 - 2013) 22 BioDiem Ltd, Ratio Charts 24 BioDiem Ltd, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 25 BioDiem Ltd, Pharmaceuticals and Healthcare, Deals by Type, 2008 to YTD 2014 26